I would not do anything differently with vaccine, AstraZeneca boss says

The French-Australian admitted there had been “setbacks” as part of the process
The recently knighted head of AstraZeneca says he would not ‘do anything differently’ despite acknowledging there had been ‘setbacks’ with the vaccine developed with Oxford University (PA)

The recently knighted head of AstraZeneca says he would not ‘do anything differently’ despite acknowledging there had been ‘setbacks’ with the vaccine developed with Oxford University (PA)

The head of AstraZeneca says he would not “do anything differently” despite acknowledging there had been “setbacks” with the vaccine developed with Oxford University.

Research released in June 2021 suggested Vaxzevria – more commonly known as the Oxford/AstraZeneca vaccine – is associated with slightly increased risk of some bleeding disorders.

You have reached your article limit. Already a subscriber? Sign in

Save €40 on an Annual Subscription.​

Continue reading within unlimited digital access and exclusive subscriber benefits.

Cancel anytime

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited